ABSTRACT: Disc degeneration is associated with low back pain for which currently there is no optimal therapy so there is a great need to identify new treatment approaches. Inorganic polyphosphates (polyP) are linear polymers of orthophosphate units varying in chain length and present in many cell types. As polyP has anabolic effects on chondrocytes, we hypothesized that polyP treatment would enhance matrix accumulation by nucleus pulposus (NP) cells. NP cells isolated from bovine caudal discs were grown in 3D culture under normoxic or in select experiments under hypoxic conditions, in the presence or absence of various concentrations and sizes of polyP. Gene expression was determined using RT-PCR. Matrix accumulation was quantified by measuring proteoglycan and collagen contents. DAPI fluorescence shift was used to stain for polyP in tissue. DAPI staining showed polyP present predominantly in the pericellular region of in vitro formed tissue. PolyP treatment enhanced matrix accumulation in a concentration and chain length dependant manner. NP cells exposed to polyP-22 (22 phosphate units length) showed an increase in gene expression of aggrecan, Collagen II, Sox 9, and MMP-13 which was maintained for the 14 days of culture. This suggests that polyP may enhance NP tissue formation in vitro by upregulating the expression of matrix genes. As polyP enhances proteoglycan accumulation even under hypoxic conditions, this raises the possibility that polyP may be a novel treatment to induce NP regeneration. ß
Low back pain (LBP) is a common disorder which has a worldwide age standardized point prevalence estimated to be 9.4%. 1 Four of every five adults experience at least one episode of LBP in their lifetimes, thus is the most common cause of disability in people below age 45 and the second most common cause (after arthritis) in the 45-65 years age group. 2 Lumbar intervertebral disc (IVD) degeneration is commonly associated with chronic LBP. 3 The process of IVD degeneration is multifactorial, involving normal ageing, biomechanical and cellular factors and genetics. 4 The IVD is a complex tissue intercalated between adjacent vertebral bodies, integrated to cartilaginous endplates, and provides flexibility and stability to the spinal column. It is composed of two tissues; an inner, central, gelatinous nucleus pulposus (NP) surrounded by a multilamellar annulus fibrosus (AF). In healthy IVDs, the main functions of the NP are weight bearing and to provide shock absorbing properties to the disc as it has high water content because of the abundant proteoglycan present in the tissue. The AF is composed of mainly fibrous, concentric lamellae comprised predominantly of collagen type I, which can adjust to weight bearing, prevent the extrusion of NP when excessive loads are applied on the IVD and, together with the cartilage endplates, restrict the swelling of the NP. 5 The factor(s) that lead to degeneration have not been entirely elucidated. Some studies suggest that calcification of endplates and subsequent deprivation of nutrients leads to NP degeneration and is an initiating event. 6 Others have proposed that rupture of AF fibers and subsequent herniation of NP tissue 7 or accelerated ageing in the NP precipitate degenerative changes in the IVD. 8 Although, the mechanism(s) of initiation of the disease is controversial there is general agreement that restoration of the proteoglycan content of the NP is one strategy that can potentially restore IVD height and relieve symptoms such as nerve compression. To achieve this, various biological therapies have been developed including cell therapies 9 or use of growth factors 10, 11 and/or bioactive molecules such as peptides and linear chain polymers. 12, 13 Bioactive compounds would be preferred over growth factors due to ease of administration and they may have fewer systemic side effects. 14 Inorganic polyphosphate (polyP) is one such bioactive compound. It is a polymer of repeated orthophosphate units, ranging from three to thousands. PolyP is widely used in toothpastes, bakery goods, and the meat industry as a preservative. 15 It is ubiquitously present in all cells, prokaryotic and eukaryotic, and its functions have been extensively studied in lower organisms such as bacteria, fungi, and parasitic protozoa. 16 PolyP is essential for survival in these lower organisms providing an alternate source of energy and maintaining virulence. Its role in mammalian cells and tissue is poorly understood although recent studies have shown polyP to regulate many essential processes in mammalian cell systems. 17 In the mammalian system, polyP has a role in coagulation, 18, 19 neuronal signal conduction, 20, 21 bone physiology including osteogenesis and bone healing, 22 and cancer biology. 23, 24 Our group has previously shown that polyP has an anabolic effect on chondrocytes and enhances cartilage tissue formation in vitro. 25 Based on this, we hypothesized that polyP treatment would enhance extracellular matrix accumulation by NP cells. Identifying a biological factor that stimulates matrix production may lead to a new therapy for treatment of early disc degeneration.
MATERIALS AND METHODS

Cell Isolation
Caudal discs (Co2-Co7) from 9-to 12-month-old calves were harvested aseptically and the nucleus pulposus (NP) was dissected out. The NP cells were then isolated by sequential enzymatic digestion with 0.25% protease in F-12 Ham's media (Sigma, St. Louis, MO) for 60 min followed by two 3 min washes with sterile phosphate buffered saline (PBS) and overnight digestion with 0.1% Collagenase A in F-12 Ham's media (Roche, Laval, Quebec, Canada) at 37˚C. The digest was passed through a cell strainer and washed three times with Ham's F-12 media.
Cell Culture and In Vitro Tissue Formation
Porous calcium polyphosphate (CPP) discs (4 mm diameter, 2 mm height) with approximately 35 volume % interconnected porosity were made by sintering calcium polyphosphate powders using methods previously described. 26 The discs were washed twice with 100% ethanol followed by two washes with MiliQ TM water at 18.2 V purity. The CPP discs were transferred to 100% ethanol again and sonicated for 10 min followed by two sequential washes with 100% ethanol and drying at 37˚C. The porous CPP discs were placed inside Tygon tubing (4.3 mm diameter, Thermoplastics Processor Inc., San Jose, CA) forming an effective containment for cell culture on the CPP discs. These tubed CPP were then autoclaved using standard cycle. NP cells were seeded as a 3D culture on the top of the CPP at a density of two million cells/disc and cultured in a 24 well tissue culture plate (Corning, New York, NY, USA) in Ham's F-12 supplemented with 20% fetal bovine serum (FBS) and 200 mg/ml Penicillin and 200 U Streptomycin (PenStrep TM , Gibco, Burlington, ON, Canada) at 37˚C and 5% CO 2 . On the 3rd day postseeding, the Tygon tubing was carefully removed and the constructs were transferred to a new culture plate. The culture media was then changed to Dulbecco's modified Eagle's media (DMEM) supplemented with 20% FBS, 1% ITS (ITSþ Premix TM , 6.25 mg/ml Insulin, 6.25 mg/ml Transferrin, 6.25 ng/ml Selenium, VWR International, Mississauga, ON, Canada), 100 mg/ml L-Ascorbic, acid 200 mg/ml Penicillin and 200 U Streptomycin in the presence or absence of polyP, of various chain lengths (22: Sperchemicals, Clearwater, FL, 45: Sigma, and 14, 60, 130: Regenetiss Inc., Tokyo, Japan), at concentrations ranging from 0.1 to 1 mM. The media was changed every 2-3 days and fresh ascorbic acid and polyP added with each media change. Selected constructs were also cultured under hypoxic conditions (2%O 2 , 5%CO 2 , and 19% nitrogen; gaseous premix Praxair, Mississauga, ON, Canada) using modular incubator chambers (Billups-Rothenberg Inc., San Diego, CA). For hypoxic cultures, the dishes were transferred to the modular incubator chambers on the day of media change to DMEM. The chambers were tightly sealed after placement of the culture plates. The chambers were then connected to the gas premix cylinder and flushed for 3 min at the rate of 5 L/min and entry and exit ports on the chamber were then clamped. The cultures were continued for various times ranging from 24 h to 14 days as defined by the experimental design. At end of the culture period, the constructs were harvested and the in vitro grown NP tissue was separated from the CPP substrate for evaluation.
DNA Quantification
NP tissues were digested for 48 h with papain (Sigma; 40 g/ ml in buffer composed of 20 mmol/L ammonium acetate, 1 mmol/L EDTA, and 2 mmol/L dithiothreitol) at 65˚C. DNA quantification was performed using the 96 well Hoechst 33258 dye binding assay (Polysciences, Warrington, PA) and fluorometry (excitation wavelength 365 nm, emmision wavelength 458 nm) as previously described. 27 The DNA content was quantified using a standard curve generated with calf thymus DNA (Sigma).
Quantification of Total Proteoglycan and Collagen Content
The proteoglycan content was determined in the in vitro formed tissues by measuring the amount of sulfated glycosoaminoglycans in aliquots of the papain digest using the dimethylmethylene blue (DMMB) dye binding assay and spectrophotometry at wavelength 525 nm as previously described. 28 The standard curve was generated using shark fin chondroitin sulfate (Sigma). Collagen content was determined by measuring the hydroxyproline content of the papain digests. One hundred microliters of the papain digests were hydrolyzed in 6 N HCl for 18 h at 110˚C, after which the hydroxyproline content was determined using the chloramine-T/Ehrlich's reagent assay and spectrophotometry at wavelength 560 nm. 29 The standard curve was generated using L-hydroxyproline (Sigma). The collagen content was determined by assuming that hydroxyproline constitutes approximately 10% of the weight of collagen. 30 Results were normalized to the total DNA content.
Alamar Blue Assay for Estimation of Metabolic Activity
After 2 weeks in culture, the constructs were transferred to new 24 well plates and incubated with 2 ml of 10% Alamar Blue TM (Life Technologies, Burlington, ON, Canada) in serum-free DMEM for 2 h as per manufacturer's instructions. An aliquot of the media (100 ml) was taken from each well and analyzed spectrophotometrically (EnVision 1 Multilabel Reader, Perkin Elmer, Waltham, MA, excitation 570 nm, emission 585 nm). The results were normalized to total DNA and expressed as arbitrary units (RFU)/mg DNA.
Live/Dead
TM Assay for Cell Viability Analysis Live/Dead TM assay was performed according to the manufacturer's instruction. After 2 weeks in culture, the in vitro formed tissue, grown in the presence or absence of polyP-22, was detached from the CPP substrate and incubated with 1 ml serum-free media containing a final working concentration of 2 mM of both Calcein-AM and Ethidinium homodimer. The tissue was incubated for 1 h and washed with PBS five times to remove unbound dye. Fluorescent images were captured using a spinning confocal microscope (Olympus) and percentage cell viability was calculate using CellC software as previously described. 31 
Gene Expression Analysis
In vitro formed NP tissue was harvested at various time points and placed in 1 ml TRIzol TM reagent (Life Technologies)
and flash frozen with liquid nitrogen. The tissue was pulverized and RNA was Trizol extracted according to the manufacturer's protocol. Total RNA was quantified using NanoDrop TM 1000 Lite Spectrophotometer (Thermo Scientific, Waltham, MA). One microgram RNA was then reverse transcribed using random primers (final concentration 0.15 mg/ml), a dNTP mixture (final concentration 0.5 mM), and Superscript II reverse transcriptase (Life Technologies). For real-time polymerase chain reaction (PCR), 5 ml SYBR Green PCR master mix (Life Technologies), 2 ml distilled water, 0.5 ml forward primer (final concentration 0.25 mM), 0.5 ml reverse primer (final concentration 0.25 mM), and 2 ml of cDNA were mixed per reaction. Sequence specific primers were used for aggrecan (ACAN), collagen type I (Col1A1), collagen type II (Col2A1), collagen type 10 (ColX), alkaline phosphatase (TNAP), Sox9, matrix metalloprotease 3 (MMP3), matrix metalloprotease 13 (MMP13), ADAMTS4, ADAMTS5, and CTSB (Table1). The ratio of gene expression relative to 18S RNA was determined using DDCt.
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Visualization of Inorganic Polyphosphates in Engineered NP Tissue DAPI a widely used fluorescent label for DNA also interacts with polyP causing a shift in its fluorescence from 475 to 525 nm (excitation at 360 nm). Fluorescence emission from free DAPI and DAPI-DNA are minimal at this wavelength, making the DAPI-poly-P signal relatively specific. This phenomenon was utilized to visualize and localize polyP in sections of engineered tissue. 33 NP tissues separated from the CPP substrate were fixed in 10% formalin overnight, embedded in paraffin and 5 mm thick sections were cut. After overnight drying at 37˚C, paraffin was removed with 100% xylene. The sections were then incubated with 10 mg/ml 4 0 ,6-diamidino-2-phenylindole (MiliQ TM water; DAPI, Invitrogen, Burlington, ON, Canada) for 10 min followed by a single 1 min wash with MiliQ TM water. Selected sections were digested with bovine alkaline phosphatase (10 mg/ml in 0.1 mM ZnCl 2 , 1 mM MgCl 2 , 50 mM KCl, 10 nM Tris pH 8.0); (Sigma) for 30 min at 37˚C to confirm the specificity of the DAPI binding to polyP. The sections were visualized using fluorescence microscopy (excitation 415 nm and emission 558 nm).
Histological Evaluation
In vitro grown NP tissue separated from the CPP substrate was fixed in 10% formalin overnight, washed thrice with Ca 2þ /Mg 2þ free PBS and then immersed in 30% sucrose for 6-8 h at 4˚C. The tissues were embedded in optimal cutting temperature compound (VWR International) and frozen overnight at À80˚C. Cryosections were cut (Jung 3000 Cryotome Leica, Wetzlar, Germany), dried overnight at 50˚C and then stained with haematoxylin and eosin or toluidine blue and coverslipped (AnaSpec, Fremont, CA). The sections were then imaged using an Olympus TM IX53 microscope with DP80 camera (Olympus, Richmond Hill, ON, Canada).
Immunohistochemical Evaluation
Prior to incubation with antibodies reactive with aggrecan, collagen type I or collagen type II, cryosections underwent enzymatic antigen retrieval with sequential incubation with pepsin (2.5 mg/ml in HCl) and hyaluronidase (25 mg/ml in PBS) for 10 and 30 min, respectively with two PBS washes 10 min each between enzyme incubations. For cytokeratin staining cryosections were boiled in Target Retrieval Solution, pH 9 (Dako, Mississauga, Ontario, Canada) at 
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Statistical Analysis
All experiments were repeated a minimum of three times using tissues obtained from different caudal spines. Each condition was done in triplicate unless specified otherwise. The results were expressed as mean AE standard deviation (SD). One way analysis of variation (ANOVA) was performed using GraphPad Prism TM (GraphPad Software Inc., La Jolla, CA) and Bonferroni's post hoc analysis was performed. Significance was assigned at p 0.05.
RESULTS
Inorganic Polyphosphates Enhances Extracellular Matrix Accumulation in a Concentration and Chain Length Dependant Manner
Since cells from different tissues respond to different chain lengths and concentrations of polyP, optimal chain length and concentration were determined for NP cells. After 2 weeks of culture, in vitro formed NP tissues were evaluated for GAG and collagen accumulation. These were maximally increased when grown in the presence of 0.5 mM polyP-22. (Fig. 1a and b) . Although other concentrations had anabolic effects, the increases were not significant. To determine if the response of NP cells was influenced by the size (chain length) of polyP, the cells were cultured in the presence of polyP of various chain lengths but an equivalent concentration of phosphate units. Both GAG and collagen accumulation was upregulated by polyP of 22 and 45 residues (Fig. 2a and b) . There was no significant difference in the response to 22 or 45 phosphate units. PolyP-22 was used in all further experiments due to its smaller size and possible ease of administration in in vivo studies. The stimulatory effect was specific to polyphosphate as monophosphates (monosodium phosphate) and diphosphates (sodium pyrophosphate) did not have an anabolic effect (Fig. S1 ). 
Inorganic Polyphosphates Enhances Matrix and DNA Accumulation Over Time
The NP tissues showed progressive accumulation of both GAG and collagen with treatment with 0.5 mM polyP (chain length 22) over time in culture. This increase was significantly different compared to the untreated cultures by day 7 and was maintained up to 14 days (Fig. 3a and b) . The GAG/collagen ratios in both untreated and polyP treated tissues were similar and increased by 7 days in culture and then plateaued. The ratios had not reached the level present in the native tissue by day 14 of culture (Fig. 3c) .
The DNA content of the untreated and polyP treated NP tissues were quantified and normalized to the DNA content of their respective control day tissues. After 1 and 7 days of polyP treatment the DNA contents of the two tissues were similar. By day 14, untreated tissues had a significantly higher DNA content compared to the polyP treated group (Fig. 3d) . The difference in DNA content was not due to cell death as Live/Dead Assay TM showed no difference in cell viability at day 14 ( Fig. S2) .
PolyP Does not Alter NP Metabolic Activity
Due to the differences in the DNA content at day14 between untreated and treated NP tissues, the effect of polyP on the metabolic state of the cells was assessed using the Alamar Blue assay TM . Untreated and polyP-treated cells had similar metabolic activities at days 7 and 14. Although there appeared to be an increase in activities between 7 and 14 days, these changes were not significant (p ¼ 0.25) (Fig. 4) .
PolyP Alters Gene Expression
The polyP-treated NP constructs had significant upregulation of Col2A1 and ACAN as early as 9 h after exposure to polyP as compared to untreated cells. This was sustained up to 14 days of culture. Col1A1, Sox9, ColX, and TNAP gene expression showed non-significant changes over the 14 days of culture (Fig. 5a ). Metalloprotease gene expression was altered as MMP13 was upregulated by 24 h and although, decreasing in amount was still significantly elevated at day 7 after which it decreased to levels similar to untreated controls. Expression levels of MMP3 and CTSB were unaffected by polyP treatment; whereas ADAMT4 and ADAMTS5 expression levels decreased, however these changes were not significant (Fig. 5b) .
PolyP Treatment Does not Alter Histological Appearance of In Vitro-Formed Tissue NP tissue formed in the presence or absence of polyP had similar morphologies. The cells formed a continuous layer of tissue rich in extracellular matrix. NP and notochordal cells were present in treated and untreated tissues (Fig. 6a, b, e, f) . The extracellular matrix showed more staining with toluidine blue in polyP exposed tissues compared to controls (Fig. 6c, d, g, h) .
To determine if polyP treatment affected the types of matrix molecules accumulated, tissue sections were immunostained for collagen type I, collagen type II and aggrecan. Both untreated and polyP-treated tissue showed an increase in staining for collagen type I, from day 7 to day 14. There was no obvious difference in staining intensity between the two groups of tissues 
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( Fig. 7a-d) . Similar increase in staining from days 7 to 14 was also observed for collagen type II and aggrecan in the tissues. However, the polyP-treated NP tissues appeared to display stronger staining for both collagen type II (Fig. 7e-h ) and aggrecan ( Fig. 7i-l) at both time points in keeping with the biochemical quantification of the content of collagen and proteoglycans. Both untreated and polyP treated groups showed presence of notochordal cells as indicated by positive staining for cytokeratin (Fig. 7m-p) .
PolyP is Present in the In Vitro-Formed NP Tissues
Green fluorescent staining indicative of polyP was seen diffusely throughout the tissue of both untreated and polyP-treated in vitro NP tissue. The polyP staining in the extracellular matrix was lost following alkaline phosphatase (an exophosphatase) pre-treatment confirming that DAPI was staining polyP. The intensity of staining in the polyP-treated tissue appeared to be greater than the untreated tissue (Fig. 8) .
PolyP Maintains Its Anabolic Effects Under Hypoxic Conditions
To determine if polyP was still effective under hypoxic conditions, matching untreated and polyP-treated cultures were maintained either under normoxic and hypoxic conditions. GAG accumulation was significantly higher in polyP treated groups in normoxic and hypoxic groups, both at days 7 and 14, compared to untreated controls At day 14, polyP-treated groups under normoxic condition had a significantly higher accumulation of GAG compared to hypoxic groups (Fig. 9a) . Only polyP-treated cultures under normoxia showed significant increase in collagen content compared to unexposed cultures. Although, polyP-treated cultures also showed increased collagen content under hypoxic conditions, the levels were not significantly different from untreated controls. PolyP-treated cultures under normoxic condition had a significantly higher accumulation of collagen compared to the hypoxic groups (Fig. 9b) . 
DISCUSSION
This study showed that, addition of polyP to NP cells in culture had a chain length specific anabolic effect and enhanced matrix accumulation of both proteoglycans and collagen which correlated with a sustained significant elevation of collagen type II and aggrecan gene expression. This effect was maintained in part, under hypoxic conditions, as enhanced proteoglycan accumulation still occurred in tissues that formed in the presence of 2% oxygen. The collagen content of the polyP treated tissues was not significantly increased in hypoxic conditions as compared to the untreated controls. This could be due to the limited time in culture. It may take more time to accumulate collagen under hypoxia as there was a trend of increasing collagen content from days 7 to 14, though the increases were not significant at both time points. This possibility is supported by the study by Mwale et al. 35 which showed 
INORGANIC POLYPHOSPHATES AND NUCLEUS PULPOSUS
47
that collagen accumulation was slower under hypoxic conditions. PolyP treatment was not toxic to cells as there was no difference between the metabolic state of untreated and polyP treated tissues. To our knowledge this is the first report of the effect of polyP on NP cells. It is not known why the effect of polyP was limited to specific chain lengths of 22 and 45 phosphate residues. PolyP chains in nature can range from a few orthophosphate monomer units to hundreds of orthophosphate units. 36 Interestingly a differential response by mammalian cell types to different chain lengths of polyP has been observed. For example polyP between 25 and 75 chain lengths enhance mineralization by bone cells, 22, 37 whereas, chondrocytes respond anabolically to polyP with a chain length of 45, 25 neurons to polyP with a chain length 60, 20, 38 and platelets to 60-100 residues. 39 One possible explanation for chain length specificity is polyP's role in forming ion channels. It has been demonstrated that polyP complexes with polyb-hydroxybutyrate to form non-specific ion channels in lipid bilayers and liposomes. 40 The proper lining of these channels is essential for them to function 41, 42 and could be the reason for the cells response to particular chain lengths of polyP as there may be differences in plasmalemma properties of individual cell types. However, this needs to be confirmed.
In our system, polyP appeared to decrease DNA content of the tissues by day 14. It is likely that polyP prevented the proliferation of NP cells, as we showed that polyP did not cause cell death or a change in the metabolic activity. We have also previously shown that polyP prevents proliferation in chondrocytes. 25 However, there are other studies have demonstrated that polyP can enhance cell proliferation. 43, 44 There are two possible explanations for this discrepancy. Firstly, it may be due to the different cell types used in these studies. Alternatively, Ozeki et al. 44 have recently demonstrated that polyP induced proliferation in dental pulp fibroblasts was mediated through MMP-3. No effect on MMP-3 expression levels was noted in polyP treated NP cells, which might explain why proliferation did not occur in our cells.
The mechanism(s) by which polyP induces anabolic changes with increased gene and macromolecular expression of aggrecan and type II collagen has yet to be elucidated. The literature suggests several ways polyP may exert these effect. Firstly, it has been shown that polyP stabilizes FGF-1 and FGF-2 binding to their receptors and enhancing the effect of growth factors up to threefold. 45 It is possible that polyP stabilizes other growth factors that could lead to anabolic effects in NP cells. Secondly, polyP can directly activate signalling pathways. For example polyP has been shown to interact with the P2Y1 receptor to activate mTOR (mammalian target of rapamycin) signalling pathway in breast cancer cells and vascular endothelium. 46, 47 Thirdly, polyphosphate kinase (PPK) with polyP as a phospho-donor, has been shown to regulate gene expression levels in lower organisms by transferring a phosphate group to nucleoside diphosphates. 48 Further studies are required to determine the mechanism(s) by which polyP enhances matrix accumulation by NP cells.
Interestingly, among the matrix degrading enzymes examined, only MMP-13 was altered by polyP treatment. Unexpectedly, it showed a significant increase in expression levels, although it gradually decreased over time. Transient increases in gene expression of matrix degrading enzymes have previously been reported with other bioactive agents and growth factors. 12, 49 It is possible that this change may not reflect a tissue degradative process, but may be a response by the cells to remodel the newly laid down matrix to obtain tissue which more closely resembles the native tissue. 50 A shortcoming of this study is that bovine and not human NP cells were utilized. Additional studies are required to determine if human NP cells respond in the same way and whether the grade of degeneration of the tissue from which the cells are isolated influences that response.
In conclusion, polyP is a naturally occurring biomacromolecule which has the ability to regulate matrix production and accumulation by NP cells. Determination as to whether human NP cells will respond similarly to polyP is necessary to facilitate its clinical translation as a therapeutic agent in the treatment early stages of disc degeneration.
AUTHORS' CONTRIBUTIONS
RG designed and performed the experiments, analyzed the data and wrote the manuscript. TS and RP designed the experiments and reviewed the manuscript. RK secured the funding, designed the experiments and reviewed the data and the manuscript. All authors approved the final draft of the manuscript.
